rationing antiretroviral therapy for hivaids in africa choices and consequences配给抗逆转录病毒疗法在非洲的条件选择和后果.pdfVIP

Open access, freely available online Policy Forum Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Choices and Consequences Sydney Rosen*, Ian Sanne, Alizanne Collier, Jonathon L. Simon n the past three years, expanding achieving a socially access to antiretroviral therapy desirable outcome I(ART) for HIV/AIDS has become a from the global global objective and a national priority intervention now for many countries in sub-Saharan being launched Africa. Large-scale treatment programs will be higher if have been launched in countries an open public- spanning the continent from Lesotho policy debate to Ghana, paid for by domestic funds is conducted mobilized by African governments and and policies are by international donor contributions. selected that make While these funds, which reach into transparent the the billions of dollars, will pay for ART trade-offs inherent for many thousands of HIV-positive in any rationing Africans, there is almost no chance that system. We also African countries will have the human, identifi ed a infrastructural, or fi nancial resources number of possible to treat everyone who is in need. rationing systems National plans for treatment rollout and proposed typically call for a specifi c number of several criteria patients to initiate therapy within the that could be used fi rst one or two years of the program. to select among Though the target patient numbers are them. In this extremely ambiti